Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8
Authors:
- 17 December 2024
- journal article
- research article
- Published by Elsevier in Acta Tropica
- Vol. 261, 107501
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2018R1A6A1A03025124)
This publication has 37 references indexed in Scilit:
- Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infectionInternational Immunopharmacology, 2023
- Immune responses to Toxoplasma gondiiCurrent Opinion in Immunology, 2022
- The unique biology of germinal center B cellsImmunity, 2021
- Serology for Toxoplasma in Immunocompromised Patients: Still Useful?Trends in Parasitology, 2021
- Control of human toxoplasmosisInternational Journal for Parasitology, 2021
- Toxoplasma gondii: An Underestimated Threat?Trends in Parasitology, 2020
- Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in miceMicrobial Pathogenesis, 2020
- A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunizationMicrobial Pathogenesis, 2019
- Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challengeActa Tropica, 2016
- Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosisParasitology Research, 2010